SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-025835
Filing Date
2021-06-24
Accepted
2021-06-24 21:12:31
Documents
2
Period of Report
2021-06-24

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3017
2 EX-24 DOCUMENT attachment1.htm EX-24 4756
  Complete submission text file 0000899243-21-025835.txt   9312
Mailing Address 279 EAST GRAND AVENUE, SUITE 430 SOUTH SAN FRANCISCO CA 94080
Business Address 279 EAST GRAND AVENUE, SUITE 430 SOUTH SAN FRANCISCO CA 94080 (650) 484-0886
Graphite Bio, Inc. (Issuer) CIK: 0001815776 (see all company filings)

IRS No.: 844867570 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O HARPOON THERAPEUTICS, INC. 131 OYSTER POINT BOULEVARD, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address
Viney Joanne L. (Reporting) CIK: 0001816744 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40532 | Film No.: 211044416